Mycodern S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was PLN 2.94 million compared to PLN 0.71289 million a year ago. Net loss was PLN 7.53 million compared to PLN 0.792467 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 PLN | -.--% | -.--% | -37.12% |
05-15 | Mycodern S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-14 | Mycodern S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-37.12% | 13.87M | |
+0.52% | 289B | |
-6.27% | 91.47B | |
-7.36% | 41.98B | |
+2.28% | 41.91B | |
+5.38% | 39.9B | |
+3.58% | 38.04B | |
-15.10% | 30.24B | |
-5.86% | 28.57B | |
+8.15% | 24.63B |
- Stock Market
- Equities
- MCD Stock
- News Mycodern S.A.
- Mycodern S.A. Reports Earnings Results for the Full Year Ended December 31, 2023